Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
Brandes AA, Bartolotti M, Marucci G, Ghimenton C, Agati R, Fioravanti A, Mascarin M, Volpin L, Ammannati F, Masotto B, Gardiman MP, De Biase D, Tallini G, Crisi G, Bartolini S, Franceschi E. Brandes AA, et al. Among authors: agati r. Crit Rev Oncol Hematol. 2015 Jun;94(3):348-59. doi: 10.1016/j.critrevonc.2014.12.016. Epub 2014 Dec 31. Crit Rev Oncol Hematol. 2015. PMID: 25600839 Review.
Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?
Franceschi E, Bartolotti M, Paccapelo A, Marucci G, Agati R, Volpin L, Danieli D, Ghimenton C, Gardiman MP, Sturiale C, Poggi R, Mascarin M, Balestrini D, Masotto B, Brandes AA. Franceschi E, et al. Among authors: agati r. J Neurooncol. 2016 Jun;128(2):235-40. doi: 10.1007/s11060-016-2097-x. Epub 2016 Mar 3. J Neurooncol. 2016. PMID: 26940908
O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications.
Brandes AA, Franceschi E, Tosoni A, Bartolini S, Bacci A, Agati R, Ghimenton C, Turazzi S, Talacchi A, Skrap M, Marucci G, Volpin L, Morandi L, Pizzolitto S, Gardiman M, Andreoli A, Calbucci F, Ermani M. Brandes AA, et al. Among authors: agati r. Neuro Oncol. 2010 Mar;12(3):283-8. doi: 10.1093/neuonc/nop050. Epub 2010 Feb 1. Neuro Oncol. 2010. PMID: 20167816 Free PMC article.
Post progression survival in glioblastoma: where are we?
Franceschi E, Ermani M, Bartolini S, Bartolotti M, Poggi R, Tallini G, Marucci G, Fioravanti A, Tosoni A, Agati R, Bacci A, Pozzati E, Morandi L, Balestrini D, Ghimenton C, Crisi G, Brandes AA. Franceschi E, et al. Among authors: agati r. J Neurooncol. 2015 Jan;121(2):399-404. doi: 10.1007/s11060-014-1651-7. Epub 2014 Nov 1. J Neurooncol. 2015. PMID: 25366365
AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.
Brandes AA, Finocchiaro G, Zagonel V, Reni M, Caserta C, Fabi A, Clavarezza M, Maiello E, Eoli M, Lombardi G, Monteforte M, Proietti E, Agati R, Eusebi V, Franceschi E. Brandes AA, et al. Among authors: agati r. Neuro Oncol. 2016 Sep;18(9):1304-12. doi: 10.1093/neuonc/now035. Epub 2016 Mar 6. Neuro Oncol. 2016. PMID: 26951379 Free PMC article. Clinical Trial.
Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study.
Brandes AA, Finocchiaro G, Zagonel V, Reni M, Fabi A, Caserta C, Tosoni A, Eoli M, Lombardi G, Clavarezza M, Paccapelo A, Bartolini S, Cirillo L, Agati R, Franceschi E. Brandes AA, et al. Among authors: agati r. Oncotarget. 2017 Feb 25;8(33):55575-55581. doi: 10.18632/oncotarget.15735. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903444 Free PMC article.
91 results